Research to Reality (R2R2022) is pleased to announce a call for LATE BREAKING ABSTRACTS for our 2022 conference. Our conference acknowledges the principle that all voices should have a platform to share knowledge and experience. With this in mind, we welcome submissions for research, program or policy abstracts for 5 minute oral presentations as well as posters.
The full call for late-breaking abstracts can be downloaded at one of the links below.
The submission deadline is Monday, March 21, 2022.
To submit your abstract, visit the Abstract Submission Portal.
The submission deadline is Monday, March 21, 2022.
There are four streams for abstract submissions:
- Neuroscience and clinical applications – this stream will include research ranging from pre-clinical to clinical research studies of psychedelic compounds and treatment protocols, as well as observational studies focusing on clinical and psychosocial outcomes;
- Traditional medicine and cultural considerations – this stream will include studies and review papers on the use of traditional medicine/traditional healing approaches, including but not limited to the use of entheogens or psychedelic medicines for healing and wellness in different cultural contexts, anthropological studies of psychedelics in folk medicine, and Indigenous methodologies.
- Public health – this stream will include epidemiological and health services research on the potential impact of psychedelic-assisted therapies on the organization of mental health and addiction treatment services, the potential demand for services, potential risk, and unintended consequences, and the influence of psychedelics and psychedelic-assisted therapies on population health.
- Policy and regulatory directions – this stream will include policy research and analysis on key factors shaping policies and regulations related to psychedelic-assisted therapies and medicine.
R2R2022 is seeking abstracts for scientific presentations as well as presentations for program descriptions, commentaries, literature syntheses, case studies, and personal narratives from lived and living experience.
Abstracts should be 500 words or less in English or French. All abstracts will be reviewed and scored based on their Aims, Conclusions, Quality, and Potential Impact. Scientific abstracts must also include Methods and Results sections. Abstracts should also clearly indicate their funding support, author affiliations, and any potential conflicts of interest. “Any funding received over the past three years from drug companies, private treatment programs, the alcohol or tobacco industry, for example, should be declared.
We are requiring presenters to consider ethnicity, race, sex, gender, and other forms of diversity as part of their work to help create more useful and specific evidence, guidance, and perspectives for different groups of people. Additionally, if your study focused on a specific population (e.g., Indigenous peoples, people with lived of living experience, youth, etc.), we are asking presenters to describe their engagement with this population. For all abstracts, as part of the submission process, you will be asked to provide a brief summary (100 words or less) about how your project has considered diversity, equity, and inclusion.
